MARKET

EOLS

EOLS

Evolus
NASDAQ
9.94
+0.14
+1.38%
Opening 10:24 05/12 EDT
OPEN
10.10
PREV CLOSE
9.80
HIGH
10.17
LOW
9.77
VOLUME
249.61K
TURNOVER
--
52 WEEK HIGH
17.82
52 WEEK LOW
8.67
MARKET CAP
640.56M
P/E (TTM)
-11.1843
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Evolus (EOLS) and GeneDx Holdings (WGS)
TipRanks · 43m ago
Weekly Report: what happened at EOLS last week (0505-0509)?
Weekly Report · 3h ago
Stifel Nicolaus Sticks to Their Buy Rating for Evolus (EOLS)
TipRanks · 4d ago
What Analysts Are Saying About Evolus Stock
Benzinga · 4d ago
Evolus’s Strong Market Position and Growth Prospects Justify Buy Rating Despite Revenue Miss
TipRanks · 4d ago
Evolus’s Growth Potential and Market Resilience: Analyst Recommends Buy Rating
TipRanks · 4d ago
Evolus: Strong Growth Potential and Market Expansion Drive Buy Rating
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Arcus Biosciences (RCUS)
TipRanks · 4d ago
More
About EOLS
More
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.
Recently
Symbol
Price
%Change

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.